Consensual diagnostic criteria for facioscapulohumeral dystrophy (FSHD) inc
lude onset of the disease in facial or shoulder girdle muscles, facial weak
ness in more than 50% of affected family members, autosomal dominant inheri
tance in familial cases, and evidence of myopathic disease in at least one
affected member without biopsy features specific to alternative diagnoses.
Six patients did not meet most of these criteria but were diagnosed as FSHD
by DNA testing, which showed small EcoRI fragments on chromosome 4q.
Their clinical signs and symptoms and results of auxiliary investigations a
re reported. The patients presented with foot extensor, thigh, or calf musc
le weakness. None of them had apparent facial weakness, only one complained
of weakness in the shoulders, none had a positive family history. Expert p
hysical examination, however, showed a typical facial expression, an abnorm
al shoulder configuration on lifting the arms, or scapular winging. This ra
ised the suspicion of FSHD, whereupon DNA analysis was done. In conclusion,
the clinical expression of FSHD is much broader than indicated by the nome
nclature. The possibility to perform DNA tests is likely to greatly expand
the clinical range of FSHD.